Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados Arq. Bras. Med. Vet. Zootec. (1) Braz. J. Vet. Res. Anim. Sci. (1) Autor CABRAL,Kenio Gouveia (1) CUNHA,Eva Laurice Pereira (1) Cardoso,C.S. (1) Contesini,E.A. (1) Ferreira,K.C. (1) Garcez,T.N.A. (1) Gerardi,D.G. (1) LANGONI,Hélio (1) Möschbacher,P.D. (1) SEABRA JÚNIOR,Rui (1) Mais... Palavra-chave Immunomodulators (2) Actinic dermatitis (1) Cat (1) Immunity (1) Leptospira (1) Oncology (1) Mais... Tipo do documento Info:eu-repo/semantics/article (2) Ano 2012 (1) 2001 (1) País Brazil (2) Idioma Inglês (2)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 2 Primeira ... 1 ... Última Baypamun® action in hamsters experimentally infected with Leptospira interrogans serogroup Canicola Braz. J. Vet. Res. Anim. Sci. LANGONI,Hélio; SEABRA JÚNIOR,Rui; CABRAL,Kenio Gouveia; CUNHA,Eva Laurice Pereira. Baypamun® is an immunity modulator recommended as prophylactic and therapeutic use. In the present study, this product was used in the hamsters experimentally infected with Leptospira interrogans serogroup canicola. The animals were divided in 5 groups, with 20 animals each. This product was used as a therapeutic, prophylactic and as adjuvant. As a therapeutic use all the animals died. Despite of eight (40.0%) survivors, the prophylactic use wasn't also totally favorable due to leptospire recovering from kidneys of those animals. Based on the analysis of antibodies levels among animals that received vaccine and vaccine with Baypamun® as adjuvante, this product didn't conferred superior humoral answer. However, other studies should be accomplished utilizing... Tipo: Info:eu-repo/semantics/article Palavras-chave: Immunomodulators; Leptospira; Immunity. Ano: 2001 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-95962001000600010 Topical treatment of actinic keratosis with imiquimod 5% cream Arq. Bras. Med. Vet. Zootec. Garcez,T.N.A.; Gerardi,D.G.; Ferreira,K.C.; Cardoso,C.S.; Möschbacher,P.D.; Contesini,E.A.. The viability and the efficiency of imiquimod 5% cream in a cat which suffered from nasal actinic keratosis were evaluated. The procedures were carried out at home by the owners themselves. Six packets of the cream were used, one per week, in three consecutive daily applications, with a four-day interval (without treatment). The cytological results were negative for neoplastic cells 30 days after the end of the treatment. A clinical revision was conducted 18 months later and the animal showed no signs of recurrence. The cream proved to be safe and efficient. There are no reports regarding efficiency in animals concerning the treatment with imiquimod 5% cream and also regarding other effects related to this treatment. A case report presenting a positive... Tipo: Info:eu-repo/semantics/article Palavras-chave: Cat; Oncology; Actinic dermatitis; Immunomodulators. Ano: 2012 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-09352012000600018 Registros recuperados: 2 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco